000 | 01514 a2200469 4500 | ||
---|---|---|---|
005 | 20250518043905.0 | ||
264 | 0 | _c20210310 | |
008 | 202103s 0 0 eng d | ||
022 | _a2013-2514 | ||
024 | 7 |
_a10.1016/j.nefro.2019.03.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBorrego Utiel, Francisco José | |
245 | 0 | 0 |
_aUrinary osmolality in patients with polycystic kidney disease: Measured or calculated? _h[electronic resource] |
260 |
_bNefrologia _c |
||
300 |
_a202-204 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntidiuretic Hormone Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aCalcium _xurine |
650 | 0 | 4 |
_aCreatinine _xurine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOsmolar Concentration |
650 | 0 | 4 |
_aPolycystic Kidney, Autosomal Dominant _xurine |
650 | 0 | 4 |
_aPotassium _xurine |
650 | 0 | 4 |
_aReceptors, Vasopressin _xdrug effects |
650 | 0 | 4 |
_aSodium _xurine |
650 | 0 | 4 |
_aTolvaptan _xtherapeutic use |
650 | 0 | 4 |
_aUrea _xurine |
650 | 0 | 4 |
_aUric Acid _xurine |
650 | 0 | 4 |
_aUrine _xchemistry |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aCamacho Reina, María Victoria | |
700 | 1 | _aMoriana Domínguez, Clara | |
700 | 1 | _aMerino García, Enoc | |
773 | 0 |
_tNefrologia _gvol. 40 _gno. 2 _gp. 202-204 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nefro.2019.03.010 _zAvailable from publisher's website |
999 |
_c29795933 _d29795933 |